发明名称 |
A GENE THERAPY SYSTEM AND METHOD USING ALPHA-MSH AND ITS DERIVATIVES |
摘要 |
Disclosed in this specification is the use alpha-MSH and/or its derivatives as an adjunct to gene therapy. In one aspect, the gene therapy vector includes nucleic acids that expresses alpha-MSH and/or its derivatives. Inflammatory or immune response gene promoter may control the expression of alpha-MSH and/or its derivatives. The sequences may also be expressed together with a therapeutic gene using an internal ribosomal entry site sequence. In another aspect, pharmacologically effective amount of alpha-MSH and/or its derivativ es may be administered before, after, or concurrently with the gene therapy vector carrying the appropriate gene.
|
申请公布号 |
CA2406755(A1) |
申请公布日期 |
2001.11.08 |
申请号 |
CA20012406755 |
申请日期 |
2001.04.27 |
申请人 |
ZENGEN INC. |
发明人 |
LIPTON, JAMES M.;CATANIA, ANNA P. |
分类号 |
C12N15/09;A61K35/76;A61K38/22;A61K47/48;A61K48/00;A61P7/04;A61P35/00;A61P43/00;(IPC1-7):A01N43/04;A61K31/70;C12N15/00;C12N15/63;C12N15/70;C12N15/74;C12N15/85;C12N15/87 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|